Rho Ventures (also known as Rho Capital Partners) is a long-standing venture capital firm headquartered in New York, NY, USA, with a track record dating back to 1981 and a broad investment footprint spanning seed through growth stages across technology sectors like software, biotech, health care, and information technology.

Seed: Participates as a seed and early institutional investor, often co-leading rounds.
Series A / Series B: Active in Series A and Series B, frequently taking lead or significant co-lead positions.
Growth & Later: Invests in later venture and growth rounds based on company trajectory and thesis fit.

Typical Check Size: Large relative to pure seed funds — often $5M–$25M+ per round, especially in Series A/B.
Typical Ownership Taken (Company Stakes):
• Rho typically targets meaningful minority equity positions in rounds it leads or co-leads rather than fixed small angel stakes. Because Rho invests larger, later tickets, equity stakes for early institutional rounds generally fall in the range of ~8%–15% when Rho is a lead or major participant.
• In growth rounds, its ownership can vary significantly based on valuation and prior dilution — but maintains non-controlling but strategic stakes.
Ownership Style: Minority but substantial — Rho often negotiates for board seats or observer rights when its economic interest and participation warrant governance influence (standard for institutional VC leads).
Equity Structure: Preferred equity in priced rounds is typical for Series A/B.

 Submission Method: Rho does not publicly offer a standard online application for founders; engagements typically occur via warm introductions, referrals from co-investors, or targeted outreach aligned with the firm’s thesis.
Lead Stance: Capable of leading or co-leading institutional rounds with strategic syndicate partners.
Review Cadence: Rolling, based on deal flow, company fit, and investment committee decisions.

Sector Focus: Broad technology and innovation across software/SaaS, health care/biotech, IT, industrial tech, and related domains.
Geography: U.S.-primary with some international activity; majority of investments are U.S.-based.
Stage: Seed through growth equity, with strongest activity in Series A and B. 
Company Profile: Venture-scale businesses with validated models and scaling trajectories; many companies have demonstrable revenue or traction. 
Team: Founders or executive teams with strong domain experience and execution capacity.

Initial Intake: Review of deck, traction, and market opportunity.
 Partner Evaluation: Deep evaluation of team, product, tech differentiation, and business model.
 Due Diligence: Market, financial, product, and reference diligence.
 Deal Structuring: Terms negotiated to balance founder retention with institutional ownership aligned to growth capital deployment.

Strategic Capital: Institutional capital across early and growth stages tailored to expansion goals. 
Operational Support: Board-level guidance, network access, and strategic introductions.
Follow-On Support: Pro-rata participation in later rounds via established relationships.